Related Experiment Video
Updated: Sep 2, 2025

Author Spotlight: Advancements in Multiplex Detection of Respiratory Viruses
Published on: November 10, 2023
Contributing factors to pediatric COVID-19 and MIS-C during the initial waves: A systematic review of 92 case reports
Muzna Sarfraz1, Azza Sarfraz2, Zouina Sarfraz3
1CMH Lahore College, Lahore, Pakistan.
Insights
Pediatric COVID-19 cases were analyzed, identifying congenital defects and genetic factors as key contributors. Understanding these factors is crucial for managing pediatric COVID-19 and MIS-C.
Area of Science:
- Pediatric Infectious Diseases
- Epidemiology
- Public Health
Background:
- Coronavirus disease 2019 (COVID-19) has disproportionately affected adults compared to children.
- Pediatric COVID-19 cases, though fewer, present unique challenges and contributing factors.
- This study systematically reviews case reports to understand these pediatric-specific elements.
Purpose of the Study:
- To identify and analyze the contributing factors for confirmed coronavirus disease 2019 (COVID-19) cases in the pediatric population.
- To investigate factors associated with pediatric Multisystem Inflammatory Syndrome in Children (MIS-C).
- To provide insights for future management and vaccination strategies for pediatric COVID-19.
Main Methods:
- A systematic review of case reports was conducted.
- Databases searched included PubMed and Cochrane Central between December 2019 and December 2020.
- Keywords used were "pediatrics," "Case reports," "Cases," and "Covid-19."
Main Results:
- A total of 92 records were analyzed, with 58% of patients being male and a mean age of 6.2 years.
- Contributing factors for MIS-C included G6PD deficiency (17.6%) and Group A streptococcus co-infection (17.6%).
- Factors for pediatric COVID-19 included congenital defects (18.5%), genetic defects (13.8%), and vertical/infancy transmission (16.9%).
Conclusions:
- The pediatric population remains susceptible to COVID-19, especially with community transmission.
- Identifying contributing factors like congenital issues and genetic predispositions is vital for pediatric COVID-19 and MIS-C.
- These findings can inform guidelines for managing and potentially vaccinating children against COVID-19.
Background:
As the coronavirus disease 2019 (COVID-19) pandemic continues to sweep the world with unprecedented speed and devastation, data has shown that cases in the pediatric population have been significantly lower than in the adult population. We conducted a systematic review of case reports to identify the contributing factors of confirmed pediatric COVID-19 patients.
Methods:
Using the PubMed platform, and Cochrane Central, we searched for primary studies alone. All database searches were performed between December 2019 and December 2020. We incorporated keywords including "pediatrics," "Case reports," "Cases," "Covid-19″ into all searches.
Results:
A total of 92 records were included in this novel review. Of all patients, 58% were male and the mean age of the patients was 6.2 years (SD: 5.9). Contributing factors to MIS-C infections were G6PD deficiency (17.6%), Group A streptococcus co-infection (17.6%), infancy (11.8%), whereas those in COVID-19 pediatric patients included congenital (18.5%), and genetic defects (13.8%), in addition to vertical transmission or during infancy (16.9%). Data of baseline demographic characteristics and clinical sequelae of included COVID-19 pediatric and MIS-C patients is presented.
Conclusion:
With schools reopening and closing, the pediatric age group is susceptible to high rates of COVID-19 community transmission. We provide insights into potential contributing factors to pediatric COVID-19 and MIS-C patients. These insights are critical to guide future guidelines on the management and potential vaccination efforts.
More Related Videos
09:03Nasal Brushing Sampling and Processing Using Digital High Speed Ciliary Videomicroscopy – Adaptation for the COVID-19 Pandemic
Published on: November 7, 2020
09:01An In vitro Model to Study Immune Responses of Human Peripheral Blood Mononuclear Cells to Human Respiratory Syncytial Virus Infection
Published on: December 10, 2013
Related Concept Videos
COPD: Pathogenesis and Clinical Features
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
Myocarditis II: Clinical Features and Diagnostic Tests
Pulmonary Cycle: Exhalation
Pneumonia II: Pathophysiology
Pneumonia I: Introduction
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...